Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2431714
Max Phase: Preclinical
Molecular Formula: C34H42N4O6
Molecular Weight: 602.73
Molecule Type: Small molecule
Associated Items:
ID: ALA2431714
Max Phase: Preclinical
Molecular Formula: C34H42N4O6
Molecular Weight: 602.73
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](OCc3ccc4ccccc4c3)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](OCc2ccc3ccccc3c2)[C@@H]1O
Standard InChI: InChI=1S/C34H42N4O6/c35-16-27-29(39)33(42-18-20-10-12-22-6-2-4-8-24(22)14-20)28(38)34(43-27)44-32-26(37)15-25(36)31(30(32)40)41-17-19-9-11-21-5-1-3-7-23(21)13-19/h1-14,25-34,39-40H,15-18,35-38H2/t25-,26+,27-,28-,29-,30-,31+,32-,33-,34-/m1/s1
Standard InChI Key: SGJGPYIXRJKGAL-MRUDNGBMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 602.73 | Molecular Weight (Monoisotopic): 602.3104 | AlogP: 1.64 | #Rotatable Bonds: 9 |
Polar Surface Area: 181.46 | Molecular Species: BASE | HBA: 10 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.81 | CX Basic pKa: 9.54 | CX LogP: 1.42 | CX LogD: -3.29 |
Aromatic Rings: 4 | Heavy Atoms: 44 | QED Weighted: 0.16 | Np Likeness Score: 0.79 |
1. Zimmermann L, Bussière A, Ouberai M, Baussanne I, Jolivalt C, Mingeot-Leclercq MP, Décout JL.. (2013) Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues., 56 (19): [PMID:24083676] [10.1021/jm401148j] |
2. Zimmermann L, Das I, Désiré J, Sautrey G, Barros R S V, El Khoury M, Mingeot-Leclercq MP, Décout JL.. (2016) New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues., 59 (20): [PMID:27690420] [10.1021/acs.jmedchem.6b00818] |
3. Zimmermann L, Kempf J, Briée F, Swain J, Mingeot-Leclercq MP, Décout JL.. (2018) Broad-spectrum antibacterial amphiphilic aminoglycosides: A new focus on the structure of the lipophilic groups extends the series of active dialkyl neamines., 157 [PMID:30282323] [10.1016/j.ejmech.2018.08.022] |
Source(1):